IR BioSciences Holdings (IRBS) Stock Statistics & Valuation Metrics

IR BioSciences Holdings has a market cap or net worth of ―. The enterprise value is ―.

IR BioSciences Holdings has 17,083,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

IR BioSciences Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of IR BioSciences Holdings is ―. IR BioSciences Holdings’s PEG ratio is ―.

In the last 12 months, IR BioSciences Holdings had revenue of ― and earned -5.28M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

IR BioSciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

IR BioSciences Holdings upcoming earnings date is ―, TBA Not Confirmed.

IR BioSciences Holdings as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, IR BioSciences Holdings has paid ― in taxes.

IR BioSciences Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

IR BioSciences Holdings has ― in cash and marketable securities with 3.64M in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for IR BioSciences Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―